Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Zander

Showing results (271-280 of 456) with videos related to

Pageof 46
Sort By:
Bone Marrow Transplantation|May 7, 2003
Non-overt disseminated intravascular coagulation in patients during treatment with antithymocyte globulin for unrelated allogeneic hematopoietic stem cell transplantationM Weber, N Kröger, F Langer, et al.
Zahntechnik; Zeitschrift Fur Theorie Und Praxis Der Wissenschaftlichen Zahntechnik|September 1, 1979
[Development of directions of the partnership for orthodontic technic]F Schmeil, R Zander, H C Guske, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 10, 2000
CD34 splice variant: an attractive marker for selection of gene-modified cellsB Fehse, A Richters, K Putimtseva-Scharf, et al.
Bone Marrow Transplantation|June 1, 2002
Stem cell mobilisation with 16 microg/kg vs 10 microg/kg of G-CSF for allogeneic transplantation in healthy donorsN Kröger, H Renges, S Sonnenberg, et al.
Cancer Genetics and Cytogenetics|January 27, 2009
Development of AML with t(8;21)(q22;q22) and RUNX1-RUNX1T1 fusion following Philadelphia-negative clonal evolution during treatment of CML with ImatinibPhilippe Schafhausen, Judith Dierlamm, Carsten Bokemeyer, et al.
British Journal of Haematology|September 12, 1998
Mobilizing peripheral blood stem cells with high-dose G-CSF alone is as effective as with Dexa-BEAM plus G-CSF in lymphoma patientsN Kröger, W Zeller, N Fehse, et al.
Leukemia Research Reports|September 13, 2023
Allogeneic stem cell transplant for multiple myeloma & myelofibrosis with split-dose busulfan, fludarabine & cyclophosphamideAndrew D Trunk, Sagar S Patel, Josef T Prchal, et al.
Stem Cells (Dayton, Ohio)|January 17, 2003
Liver-specific gene expression in cultured human hematopoietic stem cellsHenning C Fiegel, Michael V Lioznov, Lourdes Cortes-Dericks, et al.
Annals of Internal Medicine|July 1, 1980
4'-(9-Acridinylamino) methanesulfon-m-anisidide (AMSA): a new drug effective in the treatment of adult acute leukemiaS S Legha, M J Keating, A R Zander, et al.
Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS|December 20, 2005
[Requirements and expectations for optimal volume replacement]R Zander, H A Adams, J Boldt, et al.
Pageof 46

Showing results (271-280 of 456) with videos related to

Sort By:
Pageof 46
Bone Marrow Transplantation|May 7, 2003
Non-overt disseminated intravascular coagulation in patients during treatment with antithymocyte globulin for unrelated allogeneic hematopoietic stem cell transplantationM Weber, N Kröger, F Langer, et al.
Zahntechnik; Zeitschrift Fur Theorie Und Praxis Der Wissenschaftlichen Zahntechnik|September 1, 1979
[Development of directions of the partnership for orthodontic technic]F Schmeil, R Zander, H C Guske, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 10, 2000
CD34 splice variant: an attractive marker for selection of gene-modified cellsB Fehse, A Richters, K Putimtseva-Scharf, et al.
Bone Marrow Transplantation|June 1, 2002
Stem cell mobilisation with 16 microg/kg vs 10 microg/kg of G-CSF for allogeneic transplantation in healthy donorsN Kröger, H Renges, S Sonnenberg, et al.
Cancer Genetics and Cytogenetics|January 27, 2009
Development of AML with t(8;21)(q22;q22) and RUNX1-RUNX1T1 fusion following Philadelphia-negative clonal evolution during treatment of CML with ImatinibPhilippe Schafhausen, Judith Dierlamm, Carsten Bokemeyer, et al.
British Journal of Haematology|September 12, 1998
Mobilizing peripheral blood stem cells with high-dose G-CSF alone is as effective as with Dexa-BEAM plus G-CSF in lymphoma patientsN Kröger, W Zeller, N Fehse, et al.
Leukemia Research Reports|September 13, 2023
Allogeneic stem cell transplant for multiple myeloma & myelofibrosis with split-dose busulfan, fludarabine & cyclophosphamideAndrew D Trunk, Sagar S Patel, Josef T Prchal, et al.
Stem Cells (Dayton, Ohio)|January 17, 2003
Liver-specific gene expression in cultured human hematopoietic stem cellsHenning C Fiegel, Michael V Lioznov, Lourdes Cortes-Dericks, et al.
Annals of Internal Medicine|July 1, 1980
4'-(9-Acridinylamino) methanesulfon-m-anisidide (AMSA): a new drug effective in the treatment of adult acute leukemiaS S Legha, M J Keating, A R Zander, et al.
Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS|December 20, 2005
[Requirements and expectations for optimal volume replacement]R Zander, H A Adams, J Boldt, et al.
Pageof 46